Axsome Therapeutics (AXSM) Change in Inventory (2022 - 2026)

Axsome Therapeutics has disclosed Change in Inventory across 5 years of filings, most recently posting $3.1 million for Q1 2026.

• Change in Inventory for Q1 2026 came in at $3.1 million, up 1149.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $13.5 million (up 2353.5% YoY), and the FY2025 annual result was $10.7 million, up 1532.8% from the prior year.
• Change in Inventory came in at $3.1 million for Q1 2026 at Axsome Therapeutics, down from $3.6 million in the prior quarter.
• In the past five years, Change in Inventory ranged from a high of $5.0 million in Q3 2025 to a low of -$1.7 million in Q3 2023.
• The 5-year median for Change in Inventory is $1.3 million (2023), against an average of $1.5 million.
• Across the five-year window, Change in Inventory tumbled 681.82% in 2023 and surged 1149.0% in 2026, its largest moves.
• Axsome Therapeutics' Change in Inventory stood at $1.3 million in 2022, then soared by 269.74% to $4.9 million in 2023, then slumped by 76.9% to $1.1 million in 2024, then surged by 222.41% to $3.6 million in 2025, then fell by 14.56% to $3.1 million in 2026.
• The last three Change in Inventory figures came in at $3.1 million (Q1 2026), $3.6 million (Q4 2025), and $5.0 million (Q3 2025), per Business Quant data.